Related Experiment Videos
The FDA report on intraocular lenses.
Ophthalmology
|April 1, 1983
Summary
Clinical studies on intraocular lenses (IOLs) show that 85% of patients achieve 20/40 vision one year post-surgery. Factors like patient age and complications can impact visual acuity outcomes.
Area of Science:
- Ophthalmology
- Medical Device Regulation
Background:
- Intraocular lenses (IOLs) are investigational devices regulated by the U.S. Food and Drug Administration (FDA) since 1978.
- Extensive data collection on IOLs has been ongoing, with over one million implanted by August 1982.
Purpose of the Study:
- To review clinical data on intraocular lens (IOL) implantation.
- To assess visual acuity outcomes and identify factors influencing them.
Main Methods:
- Analysis of clinical study data for intraocular lenses (IOLs).
- Review of over 45,000 cases to evaluate visual acuity one year post-surgery.
- Identification of factors affecting visual outcomes, including patient age and surgical complications.
Main Results:
- 85% of patients achieved a visual acuity of 20/40 or better one year after IOL surgery.
- Factors such as increasing patient age, surgical problems, postoperative complications, and adverse reactions were found to reduce visual acuity.
- The trend in the USA favors the implantation of posterior chamber and anterior chamber IOLs.
Conclusions:
- Intraocular lens implantation demonstrates high rates of visual acuity improvement.
- Patient-specific factors and surgical outcomes significantly influence visual results.
- Posterior and anterior chamber IOLs are the prevalent types being implanted in the United States.